Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

175.78 -0.12 (-0.07%)
Streaming Delayed Price Updated: 11:02 AM EDT, May 9, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
3 Mid-Cap Stocks with Mounting Challenges
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the many opportunities in front of them attract... 
Via StockStory
Is QUEST DIAGNOSTICS INC (NYSE:DGX) a Good Fit for Dividend Investing?
Why the dividend investor may take a look at QUEST DIAGNOSTICS INC (NYSE:DGX). 
Via Chartmill
Guardant Health (GH) Q1 Earnings Report Preview: What To Look For
Diagnostics company Guardant Health (NASDAQ:GH) will be reporting earnings tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics World Trade
Exposures Tariff
Labcorp (LH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results tomorrow before market open. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Exposures Artificial Intelligence Economy Tariff
NeoGenomics (NEO) Q1 Earnings Report Preview: What To Look For
Oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) will be reporting earnings tomorrow morning. Here’s what investors should know. 
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
QUEST DIAGNOSTICS INC (NYSE:DGX) Shows Potential for a Breakout.
The technical analysis for QUEST DIAGNOSTICS INC (NYSE:DGX) is highly positive, with a rating of 9 out of 10, suggesting a potential breakout. 
Via Chartmill
Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years
Via Benzinga
What To Expect From HCA Healthcare’s (HCA) Q1 Earnings
Hospital operator HCA Healthcare (NYSE:HCA) will be reporting earnings tomorrow before market open. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings
Via Benzinga
A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts
Via Benzinga
Encompass Health (EHC) Reports Q1: Everything You Need To Know Ahead Of Earnings
Health care services provider Encompass Health (NYSE:EHC) will be reporting results tomorrow after market close. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Which S&P500 stocks are moving on Tuesday?
Let's have a look at the top S&P500 gainers and losers one hour before the close of the markets of today's session. 
Via Chartmill
Exploring the top movers within the S&P500 index during today's session.
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
Which S&P500 stocks are gapping on Tuesday?
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session. 
Via Chartmill
Quest Diagnostics Revenue Rebound, Strategic Moves Fuel Outlook Confidence
Quest Diagnostics Q1 2025 revenue rose to $2.65 billion with EPS of $2.21, exceeding expectations; full-year guidance for sales and EPS reaffirmed. 
Via Benzinga
Quest Diagnostics Posts Better-Than-Expected Earnings, Joins Pentair, 3M, Danaher And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Quest Diagnostics’ Q1 Earnings Align With Wall Street Estimates: Retail’s In Wait-And-Watch Mode
The laboratory operator reported first-quarter adjusted diluted EPS of $2.21, representing an 8.3% growth from the corresponding period last year and meeting an analyst estimate of $2.21, according to... 
Via Stocktwits
Quest Diagnostics Looks Like A 'Safe Haven' After First-Quarter Beat
The company topped first-quarter expectations on strong requisition volume, and reaffirmed its outlook for the year. 
Via Investor's Business Daily
Chemed (CHE) Reports Earnings Tomorrow: What To Expect
Healthcare services company Chemed Corporation (NYSE:CHE) will be reporting results tomorrow after market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Quest (NYSE:DGX) Beats Q1 Sales Targets
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 12.1% year on year to $2.65 billion. The company expects... 
Via StockStory
Examining the Future: Quest Diagnostics's Earnings Outlook
Via Benzinga
Quest Earnings: What To Look For From DGX
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For April 22, 2025
Via Benzinga
3 Healthcare Stocks with Questionable Fundamentals
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But financial performance has lagged recently as players offloaded surplus COVID... 
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Peering Into Quest Diagnostics's Recent Short Interest
Via Benzinga
Price Over Earnings Overview: Quest Diagnostics
Via Benzinga
Reflecting On Testing & Diagnostics Services Stocks’ Q4 Earnings: Guardant Health (NASDAQ:GH)
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting... 
Via StockStory
Testing & Diagnostics Services Stocks Q4 Recap: Benchmarking NeoGenomics (NASDAQ:NEO)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the testing & diagnostics services stocks, including NeoGenomics (NASDAQ:NEO) and its peers. 
Via StockStory
This GE Vernova Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.